Saruhan-Direskeneli G - Search Results

1

A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.

Zisimopoulou P, Evangelakou P, Tzartos J, Lazaridis K, Zouvelou V, Mantegazza R, Antozzi C, Andreetta F, Evoli A, Deymeer F, Saruhan-Direskeneli G, Durmus H, Brenner T, Vaknin A, Berrih-Aknin S, Frenkian Cuvelier M, Stojkovic T, DeBaets M, Losen M, Martinez-Martinez P, Kleopa KA, Zamba-Papanicolaou E, Kyriakides T, Kostera-Pruszczyk A, Szczudlik P, Szyluk B, Lavrnic D, Basta I, Peric S, Tallaksen C, Maniaol A, Tzartos SJ. Zisimopoulou P, et al. J Autoimmun. 2014 Aug;52:139-45. doi: 10.1016/j.jaut.2013.12.004. Epub 2013 Dec 24. J Autoimmun. 2014. PMID: 24373505

2

HLA-DQ polymorphism in Turkish patients with myasthenia gravis.

Saruhan-Direskeneli G, Kiliç A, Parman Y, Serdaroğlu P, Deymeer F. Saruhan-Direskeneli G, et al. Hum Immunol. 2006 Apr-May;67(4-5):352-8. doi: 10.1016/j.humimm.2006.02.039. Epub 2006 Apr 7. Hum Immunol. 2006. PMID: 16720217

3

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.

Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G. Deymeer F, et al. Neurology. 2007 Feb 20;68(8):609-11. doi: 10.1212/01.wnl.0000254620.45529.97. Neurology. 2007. PMID: 17310034

4

Polymorphisms of interferon-gamma, interleukin-10, and interleukin-12 genes in myasthenia gravis.

Yilmaz V, Tütüncü Y, Bariş Hasbal N, Parman Y, Serdaroglu P, Deymeer F, Saruhan-Direskeneli G. Yilmaz V, et al. Hum Immunol. 2007 Jun;68(6):544-9. doi: 10.1016/j.humimm.2007.02.003. Epub 2007 Mar 12. Hum Immunol. 2007. PMID: 17509455

5

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis.

Li J, Qi H, Tüzün E, Allman W, Yilmaz V, Saini SS, Deymeer F, Saruhan-Direskeneli G, Christadoss P. Li J, et al. J Neuroimmunol. 2009 Mar 31;208(1-2):40-5. doi: 10.1016/j.jneuroim.2008.12.013. Epub 2009 Feb 3. J Neuroimmunol. 2009. PMID: 19193448

6

Increased complement consumption in MuSK-antibody-positive myasthenia gravis patients.

Tüzün E, Yılmaz V, Parman Y, Oflazer P, Deymeer F, Saruhan-Direskeneli G. Tüzün E, et al. Med Princ Pract. 2011;20(6):581-3. doi: 10.1159/000330031. Epub 2011 Oct 4. Med Princ Pract. 2011. PMID: 21986021 Free article.

7

Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma.

Ekizoğlu E, Yılmaz V, Içöz S, Birişik Ö, Tüzün E, Akman-Demir G, Saruhan-Direskeneli G, Deymeer F. Ekizoğlu E, et al. Muscle Nerve. 2013 Feb;47(2):306-7. doi: 10.1002/mus.23630. Muscle Nerve. 2013. PMID: 23349085 No abstract available.

8

The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes.

Marx A, Pfister F, Schalke B, Saruhan-Direskeneli G, Melms A, Ströbel P. Marx A, et al. Autoimmun Rev. 2013 Jul;12(9):875-84. doi: 10.1016/j.autrev.2013.03.007. Epub 2013 Mar 25. Autoimmun Rev. 2013. PMID: 23535159 Review.

9

Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.

Alahgholi-Hajibehzad M, Yilmaz V, Gülsen-Parman Y, Aysal F, Oflazer P, Deymeer F, Saruhan-Direskeneli G. Alahgholi-Hajibehzad M, et al. Hum Immunol. 2013 Dec;74(12):1633-5. doi: 10.1016/j.humimm.2013.08.271. Epub 2013 Aug 28. Hum Immunol. 2013. PMID: 23993985

10

Prepubertal anti-Musk positive myasthenia gravis with long remission.

Gungor-Tuncer O, Orhan EK, Yilmaz V, Parman Y, Oflazer P, Saruhan-Direskeneli G, Deymeer F. Gungor-Tuncer O, et al. Neuromuscul Disord. 2014 Jan;24(1):36-9. doi: 10.1016/j.nmd.2013.07.012. Epub 2013 Aug 14. Neuromuscul Disord. 2014. PMID: 24074501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

115 results

Search Page